The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
NU HLDGS LTD ORD SHS CL A G6683N103   18,457,848 1,431,951 SH   SOLE   1,431,951 0 0
AKERO THERAPEUTICS INC COM 00973Y108   9,943,498 423,849 SH   SOLE   423,849 0 0
89BIO INC COM 282559103   5,800,297 724,132 SH   SOLE   724,132 0 0
GE AEROSPACE COM NEW 369604301   10,982,125 69,083 SH   SOLE   69,083 0 0
ISHARES TR CORE S&P500 ETF 464287200   30,835,316 56,348 SH   SOLE   56,348 0 0
MADRIGAL PHARMACEUTICALS INC COM 558868105   12,811,717 45,730 SH   SOLE   45,730 0 0